Diversified Trust’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-21,762
Closed -$416K 975
2024
Q3
$416K Buy
+21,762
New +$451K 0.01% 643
2023
Q3
Sell
-14,060
Closed -$293K 899
2023
Q2
$293K Buy
+14,060
New +$306K 0.01% 636
2022
Q2
Sell
-14,465
Closed -$505K 825
2022
Q1
$505K Buy
14,465
+6,716
+87% +$230K 0.02% 444
2021
Q4
$236K Sell
7,749
-3,628
-32% -$118K 0.01% 715
2021
Q3
$373K Buy
+11,377
New +$364K 0.01% 504

Other funds holding OGN

Diversified Trust's OGN Position: Q4 2024 in Review

Diversified Trust sold out of Organon & Co (OGN) in Q4 2024, closing a stake of 21,762 shares — an estimated $416K sold.

Diversified Trust first reported a position in OGN in Q3 2021 and held it in 5 quarters. The position peaked at $505K in Q1 2022. 740 funds tracked by Wall St. Rank hold OGN as of Q4 2024.

  • Diversified Trust reported no remaining Organon & Co position as of Q4 2024 after selling out during the quarter.
  • Diversified Trust sold 21,762 Organon & Co shares in Q4 2024, an estimated $416K.
  • Diversified Trust first reported a position in Organon & Co in Q3 2021 and held it in 5 quarters.
  • Diversified Trust's Organon & Co position peaked at $505K in Q1 2022.
  • 740 funds tracked by Wall St. Rank held Organon & Co as of Q4 2024.

Based on Diversified Trust's 13F filing for Q4 2024, filed 7 Jan 2025.